In Brief:
Increased osteoblastic conditions demonstrated negative effects on myeloma cells proliferation and survival in this in vitro study. Taken together with clinical observation, anabolic treatment enhancing osteoblastic activity may be another therapeutic strategy not only to prevent skeletal problems but to be anti-tumor effects for myeloma.
